• Is It Wise To Import Comparator Drug From The EU To The USA? (5/18/2017) by Steffen Wais - At Fisher Clinical Services we receive thousands of requests per year to procure Rescue-Medication, Standard of Care or Comparator Medication for clinical trials across the globe. Many of these requests are for simple trials like investigator initiated trials at one site in one country or for trials only taking place within the EU or the […]
  • Clinical Research – The Supply Chain Evolution (5/11/2017) by Elizabeth Gallagher - As a reminder, the first blog in this series highlighted the advantages of expanding clinical trials in countries beyond traditional targets. For any business across borders, it is imperative to know how the language, culture, customs and religion play a role in the transaction. Success also requires incorporating the infrastructure requirements, customs (imports/exports), documentation requisites, […]
  • Clinical Ancillary Management – Advantages of Planning Ahead (5/3/2017) by Mike Yoon - If you went to the grocery store with only a mental list of items, it would cost you more time and money in the moment. Additionally, you’d probably buy some groceries that will spoil before you use them and others that will sit on your shelf for months. Another hidden cost is the one or […]
  • CLINICAL RESEARCH – SIX HELPFUL HINTS FOR EVOLVING TRIALS (4/20/2017) by Elizabeth Gallagher - In my last blog on expanding your global grasp, we explored the prospect of expanding clinical trials to regions beyond North America and Western Europe. However, even the best plans can encounter unforeseen obstacles. Today, we’d like to relay some advice that may help you circumvent variables that could delay progress. Firstly, it’s essential to […]
  • ProSyries Pre-Filled Syringe Behind The Scenes: Dedicated Cold Chain Facility & ProSyries℠ Pre-filled Syringe Tour (4/14/2017) by Guido Hunkeler - ProSyries℠ Pre-filled Syringe Packaging and Labeling It’s always a great experience to have clients visit our facility and personally show them our latest innovations (this time in pre-filled syringes) and services. Last week I had a wonderful opportunity to do exactly that with over 30 participants at our Behind the Scenes Facility Tour, part of […]
  • CLINICAL RESEARCH – EXPANDING YOUR GLOBAL GRASP (4/6/2017) by Elizabeth Gallagher - Getting your target therapeutic to patients sooner is the objective of every pharmaceutical company. At times, Sponsor companies and investigational sites can struggle to meet their clinical trial enrollment objectives. Often delays occur because the prospective sites might be limited in North America and Western Europe. Extending the trial to include other regions might add […]
  • Cold Chain Considerations for Cell Therapy Clinical Trials (3/30/2017) by Sarah Hand - This week we welcome our guest blogger, Sarah Hand, to share her thoughts on the complexities of cell therapy from a supply chain perspective. The main thing that makes cell therapy more complex from a supply chain perspective, is the requirement to maintain the drug at cryogenic temperatures prior to dosing. Cell therapy and immunotherapy […]
  • Best Practice Guidelines for importation of controlled substances to Israel. (3/23/2017) by Angus Macleod - In last week’s blog I discussed how Israel is becoming a clinical trial powerhouse. Earlier this week Fisher Clinical Services participated in the Outsourcing in Clinical Trials Israel Conference. The objective of the conference was to provide attendees with the exclusive opportunity to discuss how they develop their outsourcing strategies & improve operational efficiency in clinical […]
  • Israel is evolving into a clinical trial powerhouse – BUT understand the regulatory processes! (3/16/2017) by Angus Macleod - Israel is evolving into a clinical trial powerhouse. Its highly skilled workforce, adherence to Good Clinical Practice (GCP) and strong patient enrolment and retention rates make this a country of interest for clinical research. However, I have one top tip for you – when considering the best way to import clinical trial materials to Israel, […]
  • How US Drug Supply Chain Security Act Impacts Comparator Sourcing (3/9/2017) by Jürgen Karg - In a recent audit a new supplier was not qualified as compliant according to the Drug Supply Chain Security Act (DSCSA). This provider was declined by Fisher Clinical Services as a new supplier of comparator drugs (subsequently named reference drugs) for clinical trials. I would like to dedicate my blog today to “the positive impact […]